Monday, May 20, 2013

Important letter to Philippines Doctors and Clients

To all our valued customers and doctors,

Please be informed that with immediate effect, Lab Dom AVMM (Asia) Sdn. Bhd. will not be responsible for any representations or business endeavours undertaken by the following persons relating to MF3 of Switzerland placental cell extracts, cell therapy products or any other products related to our company or our affiliates (the “Said Products”):

Michael James Lodge
Nikolas Robert Robinson
Ronald Tai Wai Dick









The aforementioned individuals are no longer the employees of our company and are not authorized by us to distribute and/or sell the Said Products or to represent us in any manner whatsoever in the Philippines or elsewhere.

Our company will not guarantee the authenticity and the safety of any of the Said Products distributed and/or sold by the aforementioned individuals; hence we will not be liable for any complaints, claims, refunds or exchange for any reason whatsoever if you have bought any of the Said Products from any of them or from any company or any party they represent.

Until further notice, Lab Dom AVMM (Asia) Sdn. Bhd will now directly handle the distribution of the Said Products in the Philippines. If you have any enquiries regarding the sale and distribution of the Said Products in the Philippines, please write to any of our engagement managers at:

randy@labdom.com
antonio@labdom.com
dominic@labdom.com
marc@labdom.com
allan.tham@labdom.com
karen.lo@labdom.com


We sincerely apologize for any inconvenience caused and thank you for your kind co-operation.

Please click here for a digitised version of this official letter.

Friday, May 17, 2013

IMPORTANT NOTICE FROM LAB DOM

To all concerned

NOTICE

Our lawyers in Dubai have commenced legal proceedings under case registration No. 201358167 against the following two persons who are no longer our employees (since 1 May 2013 and 1 April 2013 in respect of Michael Lodge and Niklas Robinson respectively) and are not authorised to represent nor act for us in any manner whatsoever:

 
Surname:
LODGE
Given names:
MICHAEL JAMES
Nationality:
NEW ZEALAND
Passport No. :
LN441115
Date of birth :
07 Dec 1970
Place of birth :
GUILDFORD



Surname:
ROBINSON 
Given names:
NIKLAS ROBERT
Nationality:
BRITISH
Passport No. :
459793943
Date of birth :
01 May 1974
Place of birth :
STOCKHOLM




A travel ban court order has been issued by the Dubai authority against Michael Lodge and Niklas Robinson (see attached).

We enclose a search report on Michael Lodge extracted from the New Zealand authority. This report may be viewed online at: http://www.insolvency.govt.nz/oasis3-web/oasis3/page/-oasis/domain/communications/SearchInsolvencyRegister.wdk


We hereby inform all our clients (doctors, medical centres, agents and dealers), who bought or may be about to buy any Lab Dom, MF3 and Swiss Revitalisation Products and/or Services from our Lab Dom Suisse Inc.'s wholly owned clinic, Paracelsus Klinik Lustmühle, Battenhusstrasse 12, CH-9062 Lustmühle, Schweiz  from Michael Lodge or Niklas Robinson to contact us at LAB DOM AVMM SUISSE (ASIA) SDN. BHD. (address below). Any parties who have been dealing with these two persons relating to our goods and/or services may also contact us at legal@labdom.com.

We hereby inform that we have not appointed any exclusive distributors for the MENA region nor have we passed any resolution authorising Michael Lodge or Niklas Robinson to sign any distributorship agreement for the MENA region or elsewhere. Accordingly, our companies will not assume any responsibility of any kind related to any transactions with any of the above mentioned two persons.

Please visit www.labdom.com for latest news and notices from Lab Dom Suisse Group of Companies.


Yours sincerely
For and on behalf of the
Lab Dom Suisse Group of Companies
Dato’ Prof. Dr. Mike Chan
Chairman and CEO




Thursday, May 9, 2013

Distribution of MF III (MF3) and other Lab Dom products In the MENA Region

NOTICE is hereby given to all interested and/or concerned parties that the Lab Dom Group of Companies have not appointed any distributor for any part of the MENA Region (Middle East and North Africa Region) for the products known as MF III (MF3) or any other products distributed or sold by the Lab Dom Group of Companies.

Any Distribution Agreement purporting to have been signed by any of the Lab Dom Group of Companies in respect of any part of the MENA Region have not been approved nor authorised by the relevant member of Lab Dom Group and will not be recognised by the Lab Dom Group of Companies.

We have instructed our solicitors to commence civil and criminal proceedings against any people responsible for acting without authorisation from Lab Dom Group.

If you have any enquiry about the said products please contact:

CEO: Prof. Dato’ Dr. Mike Chan
ADDRESS: No. 68, Blk. K, Jln. Sulaman, Alamesra Plaza Utama,
88450 Kota Kinabalu,
Sabah,
MALAYSIA.

EMAIL: dr.mike@labdom.com

We thank you for your cooperation.


Yours sincerely
For and on behalf of the
Lab Dom Group of Companies
Prof. Dato’ Dr. MIKE CHAN
Chairman and CEO


Please click here for a digitised version of this official letter.

Tuesday, April 30, 2013

DEPARTURE OF MICHAEL LODGE

We write to inform you that Michael Lodge will no longer be an employee of our company with effect from 1st of May 2013. He is therefore no longer authorised to represent or act for the company in any manner whatsoever. We are also getting him to be removed from the boards of LAB DOM HOLDING AG, SWISS BIOLOGICAL MEDICINE GROUP AG, PARACELSUS KLINIK LUSTMÜHLE AG and PARACELSUS BIOPHARMA AG, as soon as possible.


Click here to view official letter to all concerned.



Monday, April 1, 2013

Departure of Niklas Robert Robinson

We wish to inform all concerned that Niklas Robert Robinson (British Passport No. 459793943) is no longer an employee of any of the Lab Dom Suisse Group of Companies. He is therefore no longer authorised to present or act for any of our companies in any manner whatsoever.

Click here to view official letter to all concerned.

Thursday, March 14, 2013

Leading pioneer hails Vatican on stem cells

The Vatican has been hailed by a leading pioneer as “a very powerful and supportive ally to help advance the technology of adult stem cells” to treat life-threatening diseases.

US neurosurgeon and trauma specialist Dr. Robert J. Hariri was speaking to Tracey McClure of Vatican Radio after attending a three-day Vatican-sponsored conference in late Feb entitled “Adult Stem Cells: Science and the Future of Man and Culture.”

Dr. Hariri, founder and chief executive officer of US-based Celgene Cellular Therapeutics, delivered a paper at the conference on his “research on adult stem cells in the treatment of autoimmune diseases”.

Lab Dom’s attention to Dr. Hariri’s interview with Vatican Radio was drawn by its Founder and Executive Chairman Dato’ Prof. Dr. Mike Chan.

“This is perfect news and should be included in our lectures on placenta,” said Dr Mike. “This news will put the largest religious organization in the world on the same side as us on placenta products.”

http://www.oecumene.radiovaticana.org/en1/Articolo.asp?c=536860

Listen to Tracey McClure’s full interview with Dr. Hariri here or here

梵蒂冈对干细胞态度立场,获得业界领导先锋的欢呼喝彩。

业界领导先锋热烈欢庆梵蒂冈成为“推广成人干细胞科技的强劲盟友以协助及支持医治致命性病症。

 Robert J Hariri 医师,美国神经外科及创伤科专家,于20132月底出席在梵蒂岡所举办,为期三天的“成人干细胞:科学与人类和文化的未来”国际会议后,接受梵蒂冈电台主持人Tracey McClure 访问

 Hariri 医师 为美国新基细胞治疗公司的创办人兼行政总裁。Hariri 医师于该国际会议上发表一篇以“成人干细胞医治自体免疫病的研究”为标题的专题演讲。

Lab Dom 创办人兼执行主席,陈麦克教授对Hariri 医师于梵蒂冈电台的访问深表关注,并称:“这则消息足令我公司的胎盘素产品与世界最大宗教组织处于同一看法上。乃是最佳新闻,必须纳入我公司在日后的胎盘素讲解介绍”

以下链接为Hariri医师的全程访谈录音:

http://www.oecumene.radiovaticana.org/en1/Articolo.asp?c=536860

Listen to Tracey McClure’s full interview with Dr. Hariri here or here